Abstract 1974: Prostate cancer lineage states detected by circulating tumor cell RNA sequencing are prognostic biomarkers for overall survival and resistance to androgen receptor pathway inhibitors and177Lutetium-PSMA-617
Joshua M. Lang(University of Wisconsin–Madison), Rana R. McKay(University of California San Diego), Andrew J. Armstrong(Duke University), Xiao X. Wei(Dana-Farber Cancer Institute), Marina N. Sharifi(University of Wisconsin–Madison), Jamie M. Sperger(University of Wisconsin–Madison), Amy K. Taylor(University of Wisconsin–Madison), Christos Kyriakopolous(University of Wisconsin–Madison), David Kosoff(University of Wisconsin–Madison), Hamid Emamekhoo(University of Wisconsin Carbone Cancer Center)
Cited by 0
Related Papers
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k